Morphic
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Morphic and buy or sell other stocks, ETFs, and their options commission-free!About MORF
Morphic Holding, Inc., operates as a biopharmaceutical company, which researches and develops oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas.
CEOPraveen P. Tipirneni, MD, MBA
CEOPraveen P. Tipirneni, MD, MBA
Employees—
Employees—
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2014
Founded2014
Employees—
Employees—
MORF Key Statistics
Market cap2.86B
Market cap2.86B
Price-Earnings ratio-15.81
Price-Earnings ratio-15.81
Dividend yield—
Dividend yield—
Average volume538.29K
Average volume538.29K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$57.00
52 Week high$57.00
52 Week low$19.35
52 Week low$19.35
Stock Snapshot
With a market cap of 2.86B, Morphic(MORF) trades at $56.99. The stock has a price-to-earnings ratio of -15.81.
Morphic(MORF) stock opened on 2025-11-18 at —. The price climbed to — and dipped to —.
The Morphic(MORF)'s current trading volume is 0, compared to an average daily volume of 538.29K.
During the past year, Morphic(MORF) stock moved between $19.35 at its lowest and $57.00 at its peak.
During the past year, Morphic(MORF) stock moved between $19.35 at its lowest and $57.00 at its peak.
People also own
Based on the portfolios of people who own MORF. This list is generated using Robinhood data, and it’s not a recommendation.